About
NuvOx Pharma is a clinical-stage pharmaceutical company developing NanO₂, a first-in-class oxygen therapeutic drug intended to improve oxygen delivery from lungs to tissues, targeting conditions such as stroke, oncology, and respiratory distress.
Explore NuvOx Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.